AURA · ISSUER CIK 1501796
Aura Biosciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 5 Aura Biosciences, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 1, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 202617:28 | Sep 1, 2026 | AURA | Chief People Officer | A · Grant | — | +107,611 | 107,611 | New | — | ||
| Sep 1, 202617:26 | Sep 1, 2026 | AURA | Chief Reg. & Quality Officer | A · Grant | — | +100,885 | 100,885 | New | — | ||
| Sep 1, 202617:24 | Sep 1, 2026 | AURA | Chief Medical Officer | A · Grant | — | +58,850 | 380,190 | +18% | — | ||
| Sep 1, 202617:23 | Sep 1, 2026 | AURA | SVP, Finance & PAO | A · Grant | — | +23,540 | 143,600 | +20% | — | ||
| Sep 1, 202617:21 | Sep 1, 2026 | AURA | Chief Operating Officer | A · Grant | — | +134,513 | 134,513 | New | — |